Washington Trust’s Astera Labs ALAB Stock Holding History

Washington Trust’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-140	Closed	-$8.35K	–	756
2025 Q1	$8.35K	Sell	140 -657	-82%	-$60.8K	﹤0.01%	609
2024 Q4	$106K	Hold	797	–	–	﹤0.01%	337
2024 Q3	$41.8K	Buy	+797	New	+$37.4K	﹤0.01%	476

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

Washington Trust's ALAB Position: Q2 2025 in Review

Washington Trust sold out of Astera Labs (ALAB) in Q2 2025, closing a stake of 140 shares — an estimated $8.35K sold.

Washington Trust first reported a position in ALAB in Q3 2024 and held it in 3 quarters. The position peaked at $106K in Q4 2024. 513 funds tracked by Wall St. Rank hold ALAB as of Q2 2025.

Washington Trust reported no remaining Astera Labs position as of Q2 2025 after selling out during the quarter.
Washington Trust sold 140 Astera Labs shares in Q2 2025, an estimated $8.35K.
Washington Trust first reported a position in Astera Labs in Q3 2024 and held it in 3 quarters.
Washington Trust's Astera Labs position peaked at $106K in Q4 2024.
513 funds tracked by Wall St. Rank held Astera Labs as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.